Author: George Underwood

The FDA has granted AbbVie’s potential first-in-class therapy C2N-8E12 orphan drug designation for the treatment of a rare neurodegenerative disorder.

Amgen’s leukaemia immunotherapy Blincyto has demonstrated complete remission in a phase II trial testing the drug in a new indication.

Almirall took centre stage at the PharmaTimes Sales & MSL Awards 2015 on July 9, taking home the prize for Sales Company of the Year, along with Key Account Manager of the Year, which was won by Faruk Dasu.

Mature workers greatly outnumber newer employees in the UK life sciences sector – which could possibly lead to a shortage of essential skills, according to a new survey.

Eli Lilly’s experimental lung cancer drug necitumumab has raised concerns with the FDA after trial data it suggested it could increase the chance of fatal blood clots, despite improving survival.